David Haerry joins U-PGx advisory board

David Haerry is a patients’ advocate. He is a member of the European AIDS Treatment Group (EATG). David has been involved in HIV drug development for many years and has specific interests in the areas of Personalised Medicine, Risk Communication and Doctor/Patient Communication, Pharmacovigilance, Observational Studies, Biomedical Prevention and HIV Eradication Research.

17th Golden Helix Pharmacogenomics Day in Rotterdam

The 17th Golden Helix Pharmacogenomics Day was successfully organized in Rotterdam, the Netherlands May 27th, 2016 by the Golden Helix Foundation and the Erasmus University Medical Center. Overall, the conference was attended by 164 participants from over 10 countries from Europe and the United States and was under the auspices of several national and international organizations, such as the Dutch Royal Pharmacists Association, the Genomic Medicine Alliance, the International Federation of Clinical Chemistry, and others.

Continue reading

Positive evaluation of U-PGx proposal!

H2020

We are excited to report that the U-PGx proposal PHC-24-2015 – Piloting personalised medicine in health and care systems has been favourably evaluated by the Commission in stage 2 evaluations. The project will have a funding volume of 14,9 million Euros and a duration of 60 months. The grant agreement is expected to be finalised within the next 3 months.

We want to thank all U-PGx consortium members and advisors for their help in turning the U-PGx vision into a reality and are looking forward to our future collaboration!